Skip to main content
Top
Published in: Infection 6/2014

01-12-2014 | Case Report

Fatal Strongyloides hyper-infection in a patient with myasthenia gravis

Authors: M. Saraei, B. Hosseinbigi, M. Shahnazi, B. Bijani

Published in: Infection | Issue 6/2014

Login to get access

Abstract

Purpose

We report a fatal case of Strongyloides hyper-infection as the result of corticosteroid therapy of a patient with myasthenia gravis.

Case presentation

Our patient was a farmer with a past history of living in an endemic area for Strongyloides stercoralis in Iran. Hyper-infection was diagnosed during the advanced-stage disease by demonstration of enormous number of larvae in the direct smears prepared from both the stool and tracheal secretions. Unfortunately, despite appropriate anti-parasite therapy, the patient died due to respiratory failure.

Conclusion

We recommend the provision of more awareness in high-risk people prior to immunosuppressive therapy, through screening for S. stercoralis, even in non-endemic regions.
Literature
1.
go back to reference Hakim SZ, Genta RM. Fatal disseminated strongyloidiasis in a vietnam war veteran. Arch Pathol Lab Med. 1986;110:809–12.PubMed Hakim SZ, Genta RM. Fatal disseminated strongyloidiasis in a vietnam war veteran. Arch Pathol Lab Med. 1986;110:809–12.PubMed
2.
go back to reference Sasaki Y, Tanigushi T, Kinjo M, McGill RL, McGill AT, Tsuha S, Shiiki S. Meningitis associated with strongyloidiasis in an area endemic for strongyloidiasis and human T-lymphotropic virus-1: a single-center experience in Japan between 1990 and 2010. Infection. 2013;41:1189–93.PubMedCentralPubMedCrossRef Sasaki Y, Tanigushi T, Kinjo M, McGill RL, McGill AT, Tsuha S, Shiiki S. Meningitis associated with strongyloidiasis in an area endemic for strongyloidiasis and human T-lymphotropic virus-1: a single-center experience in Japan between 1990 and 2010. Infection. 2013;41:1189–93.PubMedCentralPubMedCrossRef
3.
go back to reference Al-Hasan MN, McCormick M, Ribes JA. Invasive enteric infections in hospitalized patients with underlying strongyloidiasis. Am J Clin Pathol. 2007;128:622–7.PubMedCrossRef Al-Hasan MN, McCormick M, Ribes JA. Invasive enteric infections in hospitalized patients with underlying strongyloidiasis. Am J Clin Pathol. 2007;128:622–7.PubMedCrossRef
4.
go back to reference Moghadam KG, Khashayar P, Hashemi M. Gastrointestinal strongyloidiasis in immunocompromised patients: a case report. Acta Med Indones. 2011;43:191–4.PubMed Moghadam KG, Khashayar P, Hashemi M. Gastrointestinal strongyloidiasis in immunocompromised patients: a case report. Acta Med Indones. 2011;43:191–4.PubMed
5.
go back to reference Yassin MA, El Omri H, Al-Hijji I, Taha R, Hassan R, Aboudi KA, El-Ayoubi H. Fatal Strongyloides stercoralis hyperinfection in a patient with multiple myeloma. Braz J Infect Dis. 2010;14:536–9.PubMedCrossRef Yassin MA, El Omri H, Al-Hijji I, Taha R, Hassan R, Aboudi KA, El-Ayoubi H. Fatal Strongyloides stercoralis hyperinfection in a patient with multiple myeloma. Braz J Infect Dis. 2010;14:536–9.PubMedCrossRef
6.
go back to reference Basile A, Simzar S, Bentow J, Antelo F, Shitabata P, Peng SK, Craft N. Disseminated Strongyloides stercoralis: hyperinfection during medical immunosuppression. J Am Acad Dermatol. 2010;63:896–902.PubMedCrossRef Basile A, Simzar S, Bentow J, Antelo F, Shitabata P, Peng SK, Craft N. Disseminated Strongyloides stercoralis: hyperinfection during medical immunosuppression. J Am Acad Dermatol. 2010;63:896–902.PubMedCrossRef
7.
go back to reference Mokaddas EM, Shati S, Abdulla A, Nampoori NR, Iqbal J, Nair PM, et al. Fatal strongyloidiasis in three kidney recipients in Kuwait. Med Princ Pract. 2009;18:414–7.PubMedCrossRef Mokaddas EM, Shati S, Abdulla A, Nampoori NR, Iqbal J, Nair PM, et al. Fatal strongyloidiasis in three kidney recipients in Kuwait. Med Princ Pract. 2009;18:414–7.PubMedCrossRef
8.
go back to reference Vilela EG, Clemente WT, Mira RR, Torres HO, Veloso LF, Fonseca LP, et al. Strongyloides stercoralis hyperinfection syndrome after liver transplantation: case report and literature review. Transpl Infect Dis. 2009;11:132–6.PubMedCrossRef Vilela EG, Clemente WT, Mira RR, Torres HO, Veloso LF, Fonseca LP, et al. Strongyloides stercoralis hyperinfection syndrome after liver transplantation: case report and literature review. Transpl Infect Dis. 2009;11:132–6.PubMedCrossRef
9.
go back to reference Bava AJ, Troncoso AR. Strongyloides stercoralis hyperinfection in a patient with AIDS. J Int Assoc Physicians AIDS Care (Chic). 2009;8:235–8.CrossRef Bava AJ, Troncoso AR. Strongyloides stercoralis hyperinfection in a patient with AIDS. J Int Assoc Physicians AIDS Care (Chic). 2009;8:235–8.CrossRef
10.
go back to reference Wirk B, Wingard JR. Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation. Transpl Infect Dis. 2009;11:143–8.PubMedCrossRef Wirk B, Wingard JR. Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation. Transpl Infect Dis. 2009;11:143–8.PubMedCrossRef
11.
go back to reference Kia EB, Rahimi HR, Mirhendi H, Nilforoushan MR, Talebi A, Zahabiun F, et al. A case of fatal strongyloidiasis in a patient with chronic lymphocytic leukemia and molecular characterization of the isolate. Korean J Parasitol. 2008;46:261–3.PubMedCentralPubMedCrossRef Kia EB, Rahimi HR, Mirhendi H, Nilforoushan MR, Talebi A, Zahabiun F, et al. A case of fatal strongyloidiasis in a patient with chronic lymphocytic leukemia and molecular characterization of the isolate. Korean J Parasitol. 2008;46:261–3.PubMedCentralPubMedCrossRef
12.
go back to reference Rokni MB. The present status of human helminthic diseases in Iran. Ann Trop Med Parasitol. 2008;102:283–95.PubMedCrossRef Rokni MB. The present status of human helminthic diseases in Iran. Ann Trop Med Parasitol. 2008;102:283–95.PubMedCrossRef
13.
go back to reference Ashrafi K, Tahbaz A, Rahmati B. Strongyloides stercoralis: the most prevalent parasitic cause of eosinophilia in gilan province. Northern Iran. Iran J Parasitol. 2010;5:40–7. Ashrafi K, Tahbaz A, Rahmati B. Strongyloides stercoralis: the most prevalent parasitic cause of eosinophilia in gilan province. Northern Iran. Iran J Parasitol. 2010;5:40–7.
14.
go back to reference Fardet L, Généreau T, Poirot JL, Guidet B, Kettaneh A, Cabane J. Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J Infect. 2007;54:18–27.PubMedCrossRef Fardet L, Généreau T, Poirot JL, Guidet B, Kettaneh A, Cabane J. Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J Infect. 2007;54:18–27.PubMedCrossRef
15.
go back to reference Concha R, Harrington W Jr, Rogers AI. Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol. 2005;39:203–11.PubMedCrossRef Concha R, Harrington W Jr, Rogers AI. Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol. 2005;39:203–11.PubMedCrossRef
16.
go back to reference Nagalotimath SJ, Ramaprasad AV, Chandrashekhar NK. Fatal strongyloidiasis in a patient receiving corticosteroids. Indian J Pathol Bacteriol. 1974;17:190–2.PubMed Nagalotimath SJ, Ramaprasad AV, Chandrashekhar NK. Fatal strongyloidiasis in a patient receiving corticosteroids. Indian J Pathol Bacteriol. 1974;17:190–2.PubMed
Metadata
Title
Fatal Strongyloides hyper-infection in a patient with myasthenia gravis
Authors
M. Saraei
B. Hosseinbigi
M. Shahnazi
B. Bijani
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0637-x

Other articles of this Issue 6/2014

Infection 6/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.